-
Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States
Mar 10, 2025, 14:00 PM -
Contemporary Treatment Patterns of Patients with Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy: A Retrospective Analysis of German Claims Data
Mar 10, 2025, 14:00 PM -
Obesity Impact on Incidence of Chronic Comorbid Conditions
Mar 10, 2025, 14:00 PM -
Evaluating PICOs Requested by Member States During Scoping for EU HTA Versus Those Covered in Actual HTAs
Mar 10, 2025, 14:00 PM -
The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance
Mar 10, 2025, 14:00 PM -
Mapping the ADDQoL to the EQ-5D-5L and SF-6Dv2 among Chinese Patients with Type 2 Diabetes Mellitus
Mar 10, 2025, 14:00 PM -
China's National Reimbursement Drug List (NRDL) Negotiation: Value Considerations and Key Factors Influencing Payment Standards
Mar 10, 2025, 14:00 PM -
Exploring Contemporary Variability in PDMP Budgets and Data Sharing Across the United States
Mar 10, 2025, 14:00 PM -
Assessing the Budget Impact and Time Savings of Introducing Nivolumab and Hyaluronidase SC to Patients Receiving Nivolumab IV Across Multiple Indications on a US Healthcare Plan
Mar 10, 2025, 14:00 PM -
Trends in GLP-1 Utilization for Diabetes and Obesity in the US: A Retrospective Analysis (2017-2023)
Mar 10, 2025, 14:00 PM -
Real-World Analysis of Gastric and Gastroesophageal Junction Cancer in Mexico: Demographic and Clinical Characteristics
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Healthcare Point Solutions Versus Standard Care to Supplement Benefit Plans for Behavioral Health Adults Patients Using Real-World Synthetic Data: A Doubly Robust Causal Analysis
Mar 10, 2025, 14:00 PM -
Evaluating the Budget Impact of an Intrauterine Device for Postpartum Hemorrhage Management: A Hospital Perspective
Mar 10, 2025, 14:00 PM -
Indirect Treatment Comparison for Early Efficacy of VMAT2 Inhibitors for Tardive Dyskinesia and Chorea Associated with Huntington's Disease
Mar 10, 2025, 14:00 PM -
A US Real-World Study of Weight Trajectory and Hypothalamic Damage Among Patients With Acquired Hypothalamic Obesity
Mar 10, 2025, 14:00 PM -
A Cost Per Responder Analysis of Ritlecitinib and Baricitinib: Assessing the Impact of Clinical Efficacy and Dosing Variability on Overall Treatment Costs of Severe Alopecia Areata (AA)
Mar 10, 2025, 14:00 PM -
Advancing the Development of Real-World Data for Cancer Care in China: Challenges and Opportunities
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in HER2-Positive Early Breast Cancer in China: A Post-Hoc Analysis of the FeDeriCa Trial
Mar 10, 2025, 14:00 PM -
Advancing Health Equity in Economic Evaluations, With The Distributional Generalized Risk-Adjusted Cost-Effectiveness (DGRACE) Model
Mar 10, 2025, 14:00 PM -
Evidence for the Cumulative Impact of Social Determinants of Health (SDOH) on Cancer Mortality: A Scoping Review
Mar 10, 2025, 14:00 PM
